This Slide: #86 of 100 |
Slide #86. RTI Biologics — Pioneer Surgical Technology
Acquirer:
RTI Biologics (RTIX)
Acquiree:
Pioneer Surgical Technology
Details:
RTI Biologics Inc. (RTI) (NASDAQ:RTIX), a leading provider of orthopedic and other biologic implants, announced today its intent to acquire privately held Pioneer Surgical Technology (Pioneer), headquartered in Marquette, Mich. Pioneer is a leading medical technology company that manufactures and distributes metal and synthetic products in the orthopedics, biologics, spine, trauma and cardiothoracic markets. The acquisition of Pioneer supports RTI's strategic initiatives to expand its current implant portfolio into metals and synthetics and to grow direct distribution.
RTI Surgical is a global surgical implant company that designs, develops, manufactures and distributes biologic, metal and synthetic implants. Co. designs, manufactures, and distributes surgical implants, instruments, and biologics used in the treatment of conditions affecting the spine caused by degenerative conditions, deformities or traumatic injury. Co.' principle implant offering includes a variety of systems comprised of components such as spine screws and rods, spinal spacers, plates, and various biologics offerings designed to support, improve, or promote spinal fusion. Co. also markets and distributes its implants via relationships with Original Equipment Manufacturer distributors.
Open the RTIX Page at The Online Investor »
|
Open the RTIX Page at The Online Investor (in a new window) »
Free RTIX Email Alerts: Get SEC Filing Alerts Get Dividend Alerts |
Strong Buy (4.00 out of 4) 100th percentile
(ranked higher than approx. 100% of all stocks covered)
Based on Zacks ABR data; powered by Xignite |